title: Late noncardiac surgery in heart transplant patients.
abstract: OBJECTIVE
  Because of improved long-term survival of heart transplants (HT), patients often need noncardiac surgery (NCS). Immunosuppression may increase the infection rate. Inadequate management may increase the risk of dysfunction or acute rejection episodes (ARE). Long-term outcomes of NCS and optimal immunosuppressive management in the perioperative period are not well known. The objective of this study was to analyze the incidence, morbidity, and mortality of late NCS after HT.
  
  
  METHODS
  We retrospectively evaluated the incidence and type of late NCS as well as the risk factors for complications and the mortality among 207 HT patients. Immunosuppression and ARE rates were also analyzed.
  
  
  RESULTS
  One hundred and sixteen late NCS (84.5% elective) were performed in 72 HT patients (34.8%). Interventions were: 35 urologic (30.2%), 29 abdominal (25%), 14 vascular (12.1%), 13 ENT (11.2%), 11 skin and soft tissue (9.5%), and 7 orthopedic (6%). Malignancy was the main indication for NCS (33.6%). Only 4 patients (5.6%) died preoperatively. Mortality was higher among emergent vs elective procedures (16.6% vs 1%; P = .012) and among patients with preoperative high vs middle/low risk (26.6% vs 0%). Postsurgical infection was the most frequent complication (6.9%). However, there were no relevant complications in 82.8% of HT patients. Hospitalization time was <15 days in two thirds of patients. Immunosuppression was modified in 33 patients (28.4%), especially when the surgical indication was neoplasia (P < .001). None of the patients with NCS displayed allograft dysfunction or an ARE.
  
  
  CONCLUSIONS
  More than one-third of HT patients needed a late NCS. In our experience, elective surgical procedures with middle/low preoperative cardiovascular risk are safe. In this context, the risk of rejection was low when immunosuppression was carefully monitored to reduce the risk of infection.
authors: Area del Corazón, Complejo Hospitalario Juan Canalejo, La Coruña, Spain. raquelmarzoa@yahoo.es
authors: R
authors: R
authors: Marzoa
authors: M G
authors: MG
authors: Crespo-Leiro
authors: M J
authors: MJ
authors: Paniagua
authors: I
authors: I
authors: Bendayán
authors: R
authors: R
authors: Rios
authors: R
authors: R
authors: Franco
authors: J A
authors: JA
authors: Rodriguez
authors: E
authors: E
authors: Barge
authors: C
authors: C
authors: Naya
authors: M
authors: M
authors: Gómez
authors: J J
authors: JJ
authors: Cuenca
authors: A
authors: A
authors: Juffé
authors: A
authors: A
authors: Castro-Beiras
mesh_terms: D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D011183:Postoperative Complications / Q000145:classification / Q000601:surgery; D012189:Retrospective Studies; D013514:Surgical Procedures, Operative / Q000145:classification / Q000706:statistics & numerical data*; D013997:Time Factors